Your cart is currently empty!
Retatrutide
What is Retatrutide? Retatrutide is a novel investigational peptide currently under study as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors. Preclinical and early clinical research has focused on its potential impact on metabolic regulation, including pathways related to energy balance, insulin sensitivity, and body weight management. Scientific interest continues to grow regarding its comparative activity to other GLP-1–based compounds in research models. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
Description
“`html
| Chemical Formula | C324H446N60O68 |
| Molecular Mass | ~639.7 Da |
| CAS Number | 1270606-37-1 |
| Form | Lyophilized peptide powder |
| Shelf Life | 24 months (lyophilized) |
| Intended Use | For preclinical and in vitro research only |
| Storage | −20 °C (dry powder), −80 °C (after reconstitution) |
In experimental research settings, retatrutide is used as a tool compound to investigate the effects of simultaneous GLP-1, GIP, and glucagon receptor engagement on metabolic signaling networks. Its multi-receptor activity supports studies of receptor crosstalk, signaling integration, and downstream pathway modulation that are not fully captured by single-agonist research models.
Preclinical investigations commonly focus on receptor selectivity, signaling kinetics, and comparative activity versus incretin-based and dual-agonist investigational peptides under controlled conditions. These studies help characterize multi-pathway activation patterns and adaptive metabolic responses across different experimental designs and exposure parameters.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 10MG, 20MG, 30MG, 50MG, 5MG, KIT (10 x 10MG), KIT (10 x 20MG), KIT (10 x 30MG), KIT (10 x 50MG), KIT (10 x 5MG) |
|---|
Description
“`html
| Chemical Formula | C324H446N60O68 |
| Molecular Mass | ~639.7 Da |
| CAS Number | 1270606-37-1 |
| Form | Lyophilized peptide powder |
| Shelf Life | 24 months (lyophilized) |
| Intended Use | For preclinical and in vitro research only |
| Storage | −20 °C (dry powder), −80 °C (after reconstitution) |
In experimental research settings, retatrutide is used as a tool compound to investigate the effects of simultaneous GLP-1, GIP, and glucagon receptor engagement on metabolic signaling networks. Its multi-receptor activity supports studies of receptor crosstalk, signaling integration, and downstream pathway modulation that are not fully captured by single-agonist research models.
Preclinical investigations commonly focus on receptor selectivity, signaling kinetics, and comparative activity versus incretin-based and dual-agonist investigational peptides under controlled conditions. These studies help characterize multi-pathway activation patterns and adaptive metabolic responses across different experimental designs and exposure parameters.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 10MG, 20MG, 30MG, 50MG, 5MG, KIT (10 x 10MG), KIT (10 x 20MG), KIT (10 x 30MG), KIT (10 x 50MG), KIT (10 x 5MG) |
|---|
Reviews
There are no reviews yet.
Related products
-
Cagrilintide
$90.00 -
MOTS-C
$40.00 -
Semaglutide
Price range: $21.00 through $50.00 -
SLU-PP 332
$60.00 -
Survodutide
$165.00










Reviews
There are no reviews yet.